CLAUD - Overview: Claudin-1 Immunostain, Technical Component Only
Identification of a number of different soft tissue and epithelial neoplasms
C2FXN - Overview: C2 Complement, Functional, Serum
Investigation of a patient with a low (absent) hemolytic complement
CYSTG - Overview: Cysticercosis (Taenia solium), IgG, Serum
Aid for the diagnosis of cysticercosis caused by infection with Taenia solium
F_2 - Overview: Coagulation Factor II Activity Assay, Plasma
Diagnosing a congenital deficiency (rare) of coagulation factor II Evaluating acquired deficiencies associated with liver disease or vitamin K deficiency, oral anticoagulant therapy, and antibody-induced deficiencies (eg, in association...
C6FX - Overview: C6 Complement, Functional, Serum
Diagnosis of C6 deficiency Investigation of a patient with an undetectable total complement level
COM - Overview: Complement, Total, Serum
Detection of individuals with an ongoing immune process First-tier screening test for congenital complement deficiencies
CRT24 - Overview: Creatinine, 24 Hour, Urine
Urinary creatinine, in conjunction with serum creatinine, is used to calculate the creatinine clearance, a measure of renal function Normalizing urinary analytes to account for the variation in urinary concentration
CALU - Overview: Calcium, 24 Hour, Urine
Evaluation of calcium oxalate and calcium phosphate kidney stone risk, and calculation of urinary supersaturation Evaluation of bone diseases, including osteoporosis and osteomalacia
CACR3 - Overview: Calcium/Creatinine Ratio, Random, Urine
Evaluation of calcium oxalate and calcium phosphate kidney stone risk Calculation of urinary supersaturation Evaluation of bone diseases, including osteoporosis and osteomalacia
February 2020 - Laboratory Genetics & Genomics - Insights
A 71 yr old female with a history of a central nervous system lymphoma, an allogenic stem cell transplant and graft versus host disease was tested for...
inflammatory-bowel-disease-diagnostic-testing-algorithm.pdf
YES <50 mcg/g <50 mcg/g Abnormal >50 mcg/g Normal ANCA present ASCA IgG and IgA absent ANCA absent ASCA IgG or IgA present ANCA absent ASCA IgG or IgA absent >120 mcg/g50-120 mcg/g NO Assessing a patient...
Find out how our sarcoma panel assesses gene mutations and fusions described in more than 50 types of soft tissue, bone, and other mesenchymal tumors....
July 2019 — Cardiovascular - Insights
A 50-year-old man who was known to have systemic hypertension developed sudden onset of severe back pain with associated diaphoresis. He lost...
Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world....